ReviewHead & neck2020
Respiratory and pulmonary complications in head and neck cancer patients: Evidence-based review for the COVID-19 era.
Review in Head & neck, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 34 citations in OpenAlex.
- Postoperative Complications After Lung Cancer Resection in Patients with a Previous History of Head and Neck Cancer.Cancers · 2026Article
- Long-Term Clinical Consequences of Severe Oral Mucositis in Survivors of Lip, Oral Cavity, and Pharynx Cancer Versus Leukemia: A Propensity-Score-Matched Comparative Cohort Study Using Real-World Data.Medical sciences (Basel, Switzerland) · 2026Article
- Risk perception and avoidance of preventive behavior on the COVID-19 among cancer patients.Health science reports · 2023Article
- Effects of Semisupervised Exercise Training on Health Outcomes in People With Lung or Head and Neck Cancer: Protocol for a Randomized Controlled Trial.JMIR research protocols · 2023Article
- Co-infection associated with SARS-CoV-2 and their management.Future science OA · 2022Review
- Postoperative Delirium in Patients with Oral Cancer: Is Intraoperative Fluid Administration a Neglected Risk Factor?Cancers · 2022Article
- A loss-of-function polymorphism inOncoimmunology · 2022Article
- Feasibility and Efficacy of Inspiratory Muscle Training in Patients with Head and Neck Cancer receiving Concurrent Chemoradiotherapy.Asian Pacific journal of cancer prevention : APJCP · 2021Article
- Reduction of Elective Radiotherapy Treatment Volume in Definitive Treatment of Locally Advanced Head and Neck Cancer-Comparison of a Prospective Trial with a Revised Simulated Contouring Approach.Journal of clinical medicine · 2021Article
- Covid-19 pandemic: A new contributing factor to diagnostic and treatment delay in oral cancer patients.Oral oncology · 2021Article
- How were Non-COVID pulmonary patients and diseases affected from COVID-19 pandemic period?Turkish thoracic journal · 2021Article
- Managing head and neck cancer patients during the COVID-19 pandemic: the experience of a tertiary referral center in southern Italy.Infectious agents and cancer · 2021Review
- New Challenges of Treatment for Locally Advanced Head and Neck Cancers in the Covid-19 Pandemic Era.Journal of clinical medicine · 2021Review
- Late Complications of COVID-19; a Systematic Review of Current Evidence.Archives of academic emergency medicine · 2021Review
- Coronavirus Disease-19: Challenges Associated with the Treatment of Head and Neck Oncology and Laryngology Patients in the Coronavirus Disease-19 Era.Otolaryngologic clinics of North America · 2020Review
- Respiratory and pulmonary complications in head and neck cancer patients: Evidence-based review for the COVID-19 era.Head & neck · 2020Review
- Recommendations for head and neck surgical procedures during the COVID-19 pandemic.Clinics (Sao Paulo, Brazil) · 2020Article
- Morbidity and mortality after elective cancer surgery-How does recent Covid-19 infection impact outcome: A prospective, comparative study.Journal of anaesthesiology, clinical pharmacologyArticle
Corrections and comments
- Commented on by
Authors and funding
10 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPulmonary complications and infections frequently affect patients with head and neck squamous cell carcinoma (HNSCC). Common characteristics can predispose these patients to the development of severe respiratory illness, which may be particularly relevant during the 2019 coronavirus disease (COVID-19) pandemic.
methodsA scoping review was performed to assess the impact of pulmonary comorbidities and adverse respiratory outcomes in HNSCC patients.
resultsAdvanced age, history of tobacco and alcohol abuse, and cardiopulmonary comorbidities are significant risk factors for the development of adverse respiratory outcomes. Treatment toxicities from radiation or chemoradiation therapy significantly increase these risks.
conclusionRespiratory complications are a frequent cause of morbidity and mortality among HNSCC patients, and the COVID-19 pandemic may disproportionately affect this population. Interventions designed to decrease smoking and alcohol use, improve oral hygiene, and aggressively manage medical comorbidities are important to the long-term management and health of these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.